Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 2 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
VILMORIN & CIE manages 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 5 actions are distributed among 4 distinct examiners, indicating a slight overlap in personnel. The busiest examiner, KUBELIK, ANNE R, handles 2 pending office actions, which is a significant portion of the total actions.
The portfolio is focused within 2 distinct art units, suggesting a concentrated technical scope within the biotechnology sector. With 4 distinct examiners and only 2 art units, there is a higher likelihood of shared institutional knowledge among the examiners reviewing these 5 pending actions. The concentration of 2 actions under the busiest examiner, KUBELIK, ANNE R, allows for a more streamlined prosecution strategy for those specific matters. For the remaining actions, the company must manage the other distinct examiners. This balance between concentration under KUBELIK, ANNE R and distribution across the examiners requires a dual-track strategy: one that leverages the relationship with the busiest examiner and another that addresses the individual styles of the others within the 2 art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (67%) |
| §112 only | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUBELIK, ANNE R | 2 | 75.8% | -0.7% |
| RADOSAVLJEVIC, ALEKSANDAR | 1 | 81.7% | +8.7% |
| ORDAZ, CHRISTIAN JOSE | 1 | 61.1% | +91.7% |
| MCWILLIAMS, KELSEY LYNN | 1 | 88.9% | +5.8% |
| DELEO, VICTORIA LYNN | 1 | 41.4% | -44.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18656137 | RESISTANCE TO ToLCNDV IN SQUASH | KUBELIK, ANNE R | 23d overdue |
| 19034234 | NEW GENE RESPONSIBLE FOR CYTOPLASMIC MALE STERILITY | RADOSAVLJEVIC, ALEKSANDAR | — |
| 18907400 | CUCURBITA WITH DETERMINATE GROWTH HABIT | KUBELIK, ANNE R | — |
| 18853670 | TOLERANCE TO CGMMV IN CUCUMBER | ORDAZ, CHRISTIAN JOSE | — |
| 18294738 | RESISTANCE TO LEVEILLULA TAURICA IN PEPPER | MCWILLIAMS, KELSEY LYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18853670 | TOLERANCE TO CGMMV IN CUCUMBER | ORDAZ, CHRISTIAN JOSE | — |
| Art Unit | Apps |
|---|---|
| 1663 | 4 |
| 1662 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19034234 | NEW GENE RESPONSIBLE FOR CYTOPLASMIC MALE STERILITY | RADOSAVLJEVIC, ALEKSANDAR | 1662 | §101§102§112 | Non-Final OA | — | Pending | Jan 22, 2025 |
| 18907400 | CUCURBITA WITH DETERMINATE GROWTH HABIT | KUBELIK, ANNE R | 1663 | §102§112 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18853670 | TOLERANCE TO CGMMV IN CUCUMBER | ORDAZ, CHRISTIAN JOSE | 1663 | §101§102§112 | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18656137 | RESISTANCE TO ToLCNDV IN SQUASH | KUBELIK, ANNE R | 1663 | §101§112 | Final Rejection | 23d overdue | Pending | May 06, 2024 |
| 18294738 | RESISTANCE TO LEVEILLULA TAURICA IN PEPPER | MCWILLIAMS, KELSEY LYNN | 1663 | §101§102§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18008372 | RESISTANCE IN PLANTS OF SOLANUM LYCOPERSICUM TO THE TOBRFV | DELEO, VICTORIA LYNN | 1662 | §112 | Non-Final OA | — | Pending | Dec 05, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial